SOST and acromegaly: Interestingly, another study showed an inverse correlation between sclerostin and GH levels, suggesting that the observed decrease in Wnt antagonists’ levels (such as sclerostin) could represent a compensatory mechanism to counteract the increased bone frailty in active acromegaly [52].